Product Information
SERTRALINE 20 MG/ML ORAL CONC is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3650 per ML under NDC 59762006701. Its NADAC has been published 433 times since Jun 20, 2018.
FDA first approved this application on Dec 7, 1999. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762006701
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020990FDA Approved
12/7/1999
TE Code
AA
On Market Since
5/15/2018
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE 20 MG/ML ORAL CONC has been published 433 times since Jun 20, 2018, and over the history we have for it it has declined 52.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3650 per ML |
|---|---|
| All-time high | $0.8075 (Sep 12, 2018) |
| All-time low | $0.3017 (Jul 17, 2024) |
| 52-week high | $0.4582 |
| 52-week low | $0.3650 |
| Median price | $0.5669 |
| Average price | $0.5705 |
| Largest weekly change | +88.0% (Aug 21, 2024) |
| Weeks tracked | 433 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sertraline hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sertraline hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SERTRALINE 20 MG/ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 20 MG/ML ORAL CONC, manufactured by Mylan Pharmaceuticals Inc., is $0.3650 per ML (NDC 59762006701), effective Sep 30, 2026.
How has the price of SERTRALINE 20 MG/ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for SERTRALINE 20 MG/ML ORAL CONC has declined 52.8%. It has been tracked across 433 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for SERTRALINE 20 MG/ML ORAL CONC?
Since Jun 20, 2018, the NADAC for SERTRALINE 20 MG/ML ORAL CONC has ranged from a low of $0.3017 (Jul 17, 2024) to a high of $0.8075 (Sep 12, 2018), with a median of $0.5669 per ML.
Are there cheaper alternatives to SERTRALINE 20 MG/ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of SERTRALINE 20 MG/ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SERTRALINE 20 MG/ML ORAL CONC?
SERTRALINE 20 MG/ML ORAL CONC (NDC 59762006701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.